Insider Transactions in Q2 2021 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.09%
|
$641,350
$101.0 P/Share
|
Jun 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.74%
|
$133,350
$21.76 P/Share
|
Jun 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,410
-10.96%
|
$344,410
$101.17 P/Share
|
Jun 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,410
+9.88%
|
$75,020
$22.29 P/Share
|
Jun 14
2021
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
24,000
-60.26%
|
$2,376,000
$99.96 P/Share
|
Jun 14
2021
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+37.6%
|
$1,080,000
$45.28 P/Share
|
Jun 14
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-16.39%
|
$1,093,950
$99.84 P/Share
|
Jun 14
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
Jun 14
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$775,170
$99.91 P/Share
|
Jun 14
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
Jun 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
Jun 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-14.76%
|
$3,157,350
$97.23 P/Share
|
Jun 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
Jun 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
May 28
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
2,061
-6.92%
|
$195,795
$95.29 P/Share
|
May 25
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
4,665
-13.55%
|
$447,840
$96.09 P/Share
|
May 24
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
33,000
-7.65%
|
$3,135,000
$95.84 P/Share
|
May 24
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,000
+12.99%
|
$693,000
$21.76 P/Share
|
May 17
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69,562
+27.01%
|
-
|
May 17
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,510
-7.37%
|
$846,390
$89.49 P/Share
|
May 17
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
15,750
+19.29%
|
-
|
May 17
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,168
-11.07%
|
$904,952
$89.49 P/Share
|
May 17
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,193
+26.66%
|
-
|
May 17
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
5,233
-2.56%
|
$465,737
$89.49 P/Share
|
May 17
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
8,662
+7.75%
|
-
|
May 17
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-1.9%
|
$18,156
$89.49 P/Share
|
May 17
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
9,278
-10.97%
|
$825,742
$89.49 P/Share
|
May 17
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
15,225
+25.83%
|
-
|
May 17
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
9,907
-1.3%
|
$881,723
$89.49 P/Share
|
May 17
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
16,406
+4.12%
|
-
|
May 17
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-0.25%
|
$68,174
$89.49 P/Share
|
May 17
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,631
+6.5%
|
-
|
May 17
2021
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-6.75%
|
$101,994
$89.49 P/Share
|
May 11
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,570
-4.96%
|
$141,300
$90.4 P/Share
|
May 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-1.14%
|
$98,100
$90.4 P/Share
|
May 11
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,106
-4.03%
|
$189,540
$90.4 P/Share
|
May 11
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-2.48%
|
$24,660
$90.4 P/Share
|
May 11
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
2,028
-6.65%
|
$182,520
$90.4 P/Share
|
May 11
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
2,106
-0.57%
|
$189,540
$90.4 P/Share
|
May 11
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-0.1%
|
$12,870
$90.4 P/Share
|
May 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.09%
|
$720,360
$92.22 P/Share
|
May 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.04%
|
$274,050
$35.2 P/Share
|
May 07
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-0.18%
|
$61,789
$91.75 P/Share
|
May 07
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-0.04%
|
$4,641
$91.75 P/Share
|
May 07
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-1.25%
|
$38,948
$91.75 P/Share
|
May 07
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-1.19%
|
$12,103
$91.75 P/Share
|
May 07
2021
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
304
-1.76%
|
$27,664
$91.75 P/Share
|
May 07
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-0.95%
|
$54,964
$91.75 P/Share
|
May 07
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.35%
|
$32,942
$91.75 P/Share
|
May 07
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-1.67%
|
$48,958
$91.75 P/Share
|